Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia

Clinical Trial ID NCT00914550

Rank	Title	Journal	Year	PubWeight™‹?›
1	Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.	Am J Respir Crit Care Med	2006	4.15
2	Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia.	Thorax	2009	1.56
3	Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia.	Eur Respir J	2007	1.28
4	Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.	BMC Health Serv Res	2007	1.14
5	Markers of treatment failure in hospitalised community acquired pneumonia.	Thorax	2008	1.00
6	Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin.	Clin Infect Dis	2008	0.93
7	Making sense of scoring systems in community acquired pneumonia.	Respirology	2009	0.89
8	Prognostic value of procalcitonin in Legionella pneumonia.	Eur J Clin Microbiol Infect Dis	2008	0.85